共 359 条
[1]
D'Onofrio G(2010)Roundtable external participants and roundtable steering committee and federal participants. NIH roundtable on opportunities to advance research on neurologic and psychiatric emergencies Ann Emerg Med 56 551-564
[2]
Jauch E(2016)Traumatic brain injury: pathophysiology for neurocritical care J Intensive Care 4 29-191
[3]
Jagoda A(2013)Microglia activation as a biomarker for traumatic brain injury Front Neurol 4 30-70
[4]
Allen MH(2015)Clinical evidence of inflammation driving secondary brain injury: a systematic review J Trauma Acute Care Surg 78 184-750
[5]
Anglin D(2005)CSF proteome: a protein repository for potential biomarker identification Expert Rev Proteomics 2 57-642
[6]
Barsan WG(1999)Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins J Neurochem 72 750-348
[7]
Berger RP(2003)Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome Stroke 34 637-428
[8]
Bobrow BJ(2009)The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 1000097-83
[9]
Boudreaux ED(2020)Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: an observational study Medicine (Baltimore) 99 20922-93
[10]
Bushnell C(2018)Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction J Thromb Haemost 16 342-479